Suzanne Greenwood joined the Guild as Executive Director in August 2019. She is the former CEO of Catholic Health Australia and has held senior positions with a number of membership organisations in the health and community services sector. A lawyer by profession, Ms Greenwood was the 2017 Australian Healthcare, Pharmaceutical and Biotech Lawyer of the Year, is an experienced executive and has held numerous Board positions in the health and social services sectors.
THE Australian Government and Advanced Pharmacy Australia (AdPha) have broadly welcomed and endorsed the World Health Organization’s (WHO) new Pandemic Agreement, which lays out a coordinated global response against future outbreaks.
THE Therapeutic Goods Administration (TGA) has registered Kisunla (donanemab, Eli Lilly) for the treatment of adults with early symptomatic Alzheimer’s disease who have a specific genetic profile and the confirmed presence of amyloid plaque in the brain.
IN partnership with CARMEX
Notifications
